Comparison of Immune Response Following Surgical Management of Renal Tumors

This study has been terminated.
Information provided by (Responsible Party):
Kenneth Ogan, MD, Emory University Identifier:
First received: February 7, 2006
Last updated: September 23, 2013
Last verified: September 2013
Examine the effects of renal surgery on the immune system.

Kidney Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Comparison of Immune Response Following Surgical Management of Renal Tumors

Resource links provided by NLM:

Further study details as provided by Emory University:

Biospecimen Retention:   Samples Without DNA
Blood samples

Estimated Enrollment: 50
Study Start Date: November 2005
Study Completion Date: August 2006
Primary Completion Date: August 2006 (Final data collection date for primary outcome measure)
Detailed Description:
Prospective study examining the effects of different surgical procedures on immune function. This may have bearing on overall cancer specific recurrence and survival.

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients undergoing open or laparoscopic surgeries for the treatment of kidney tumors.

Inclusion Criteria:

  • Kidney tumor patients scheduled for open or laparoscopic surgery

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00289146

United States, Georgia
Emory University
Atlanta, Georgia, United States, 30322
Sponsors and Collaborators
Emory University
Principal Investigator: Kenneth Ogan, MD Emory University
  More Information

Responsible Party: Kenneth Ogan, MD, Associate Professor, Emory University Identifier: NCT00289146     History of Changes
Other Study ID Numbers: 0021-2005 
Study First Received: February 7, 2006
Last Updated: September 23, 2013
Health Authority: United States: Food and Drug Administration

Keywords provided by Emory University:
kidney cancer, immunology

Additional relevant MeSH terms:
Carcinoma, Renal Cell
Kidney Neoplasms
Kidney Diseases
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Urogenital Neoplasms
Urologic Diseases
Urologic Neoplasms processed this record on May 23, 2016